For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231107:nRSG6834Sa&default-theme=true
RNS Number : 6834S Cirata PLC 07 November 2023
07 November 2023
Cirata plc
("Cirata" or the "Company")
Total Voting Rights
Notification under Rule 5.6.1 Financial Conduct Authority Disclosure and
Transparency Rules:
The Company's issued share capital at 1 November 2023 consisted of 114,898,711
ordinary shares of ten pence each with voting rights admitted to trading. The
Company holds no ordinary shares in Treasury.
Therefore, the total number of voting rights in the Company is
114,898,711. This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the Company under the
DTRs.
Of the total of 114,898,711 Ordinary Shares of ten pence each:
· 114,898,711 are admitted under ISIN JE00B6Y3DV84, ticker CRTA.
For further information, please contact:
FTI Consulting +44 (0)20 3727 1137
Rob Mindell / Kwaku Aning / Matt Dixon
Stifel (Nomad and Joint Broker) +44 (0)20 7710 7600
Fred Walsh / Richard Short / Tom Marsh
Liberum (Joint Broker) +44 (0)20 3100 2000
Max Jones / Ben Cryer / Miquela Bezuidenhoudt
About Cirata
Cirata accelerates data-driven revenue growth by automating data transfer and
integration to modern cloud analytics and AI platforms without downtime or
disruption. With Cirata, data leaders can leverage the power of AI and
analytics across their entire enterprise data estate to freely choose
analytics technologies, avoid vendor, platform, or cloud lock-in while making
AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of
products and technology solutions make strategic adoption of modern data
analytics efficient and automated. For more information about Cirata,
visit www.cirata.com (http://www.cirata.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVREALFXEDKDFFA